Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101853377 | 10185337 | 7 | F | 2011 | 20160912 | 20140521 | 20160922 | EXP | US-PFIZER INC-2014137881 | PFIZER | 79.00 | YR | M | Y | 75.00000 | KG | 20160922 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101853377 | 10185337 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | 50 MG, 1X/DAY | Y | 21938 | 50 | MG | CAPSULE, HARD | QD | ||||||
| 101853377 | 10185337 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | 37.5 MG, 1X/DAY | Y | 21938 | 37.5 | MG | CAPSULE, HARD | QD | ||||||
| 101853377 | 10185337 | 3 | SS | SUTENT | SUNITINIB MALATE | 1 | 25 MG, 1X/DAY | Y | 21938 | 25 | MG | CAPSULE, HARD | QD | ||||||
| 101853377 | 10185337 | 4 | SS | SUTENT | SUNITINIB MALATE | 1 | 37.5 MG, 1X/DAY | Y | 21938 | 37.5 | MG | CAPSULE, HARD | QD | ||||||
| 101853377 | 10185337 | 5 | SS | SUTENT | SUNITINIB MALATE | 1 | 50 MG, CYCLIC (4 WEEKS ON- 2 WEEKS OFF) | Y | 21938 | 50 | MG | CAPSULE, HARD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 101853377 | 10185337 | 1 | Renal cancer metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 101853377 | 10185337 | HO |
| 101853377 | 10185337 | DE |
| 101853377 | 10185337 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 101853377 | 10185337 | Abdominal hernia | |
| 101853377 | 10185337 | Bowel movement irregularity | |
| 101853377 | 10185337 | Cerebrovascular accident | |
| 101853377 | 10185337 | Decreased appetite | |
| 101853377 | 10185337 | Disease progression | |
| 101853377 | 10185337 | Drug intolerance | |
| 101853377 | 10185337 | Dyspepsia | |
| 101853377 | 10185337 | Gait disturbance | |
| 101853377 | 10185337 | General physical health deterioration | |
| 101853377 | 10185337 | Influenza | |
| 101853377 | 10185337 | Kidney infection | |
| 101853377 | 10185337 | Memory impairment | |
| 101853377 | 10185337 | Pain in extremity | |
| 101853377 | 10185337 | Polyp | |
| 101853377 | 10185337 | Renal cancer metastatic | |
| 101853377 | 10185337 | Retching | |
| 101853377 | 10185337 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 101853377 | 10185337 | 1 | 20110211 | 0 | ||
| 101853377 | 10185337 | 2 | 20120506 | 0 | ||
| 101853377 | 10185337 | 3 | 2013 | 0 | ||
| 101853377 | 10185337 | 4 | 201401 | 0 | ||
| 101853377 | 10185337 | 5 | 201102 | 0 |